BiomarkersHumans
Plasma Neurodegeneration and AD Biomarkers Identify Populations With Rapid Cognitive Decline
GSA 2025 Abstract
Abstract
Predicting rapid cognitive decline is valuable for patient counseling and targeting clinical trials to slow down this rate of decline.


